1. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS (2017) Atherosclerosis : 19-26
    › Primary publication · 29080546 (PubMed)
  2. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia. Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MF, Khovidhunkit W, Dufour R, Garg A, McMahon MA, Pullinger CR, Sandoval NP, Hu X, Allan CM, Larsson M, Machida T, Murakami M, Reue K, Tontonoz P, Goldberg IJ, Moulin P, Charrière S, Fong LG, Nakajima K, Young SG (2017) N Engl J Med 376(17): 1647-1658
    › Primary publication · 28402248 (PubMed) · PMC5555413 (PubMed Central)
  3. A case of severe acquired hypertriglyceridemia in a 7-year-old girl. Lilley JS, Linton MF, Kelley JC, Graham TB, Fazio S, Tavori H (2017) J Clin Lipidol 11(6): 1480-1484
    › Primary publication · 28916403 (PubMed)
  4. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry. Ahmad ZS, Andersen RL, Andersen LH, O'Brien EC, Kindt I, Shrader P, Vasandani C, Newman CB, deGoma EM, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Kullo IJ, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW (2016) J Clin Lipidol 10(5): 1223-9
    › Primary publication · 27678440 (PubMed) · PMC5381273 (PubMed Central)
  5. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW (2016) Circ Cardiovasc Genet 9(3): 240-9
    › Primary publication · 27013694 (PubMed) · PMC5315030 (PubMed Central)
  6. Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis. Ormseth MJ, Yancey PG, Yamamoto S, Oeser AM, Gebretsadik T, Shintani A, Linton MF, Fazio S, Davies SS, Roberts LJ, Vickers KC, Raggi P, Kon V, Stein CM (2016) IJC Metab Endocr : 6-11
    › Primary publication · 28243578 (PubMed) · PMC5325720 (PubMed Central)
  7. Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis. Babaev VR, Ding L, Zhang Y, May JM, Lin PC, Fazio S, Linton MF (2016) Arterioscler Thromb Vasc Biol 36(4): 598-607
    › Primary publication · 26848161 (PubMed) · PMC4808396 (PubMed Central)
  8. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis. Linton MF, Babaev VR, Huang J, Linton EF, Tao H, Yancey PG (2016) Circ J 80(11): 2259-2268
    › Primary publication · 27725526 (PubMed) · PMC5459487 (PubMed Central)
  9. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition. Zhu L, Giunzioni I, Tavori H, Covarrubias R, Ding L, Zhang Y, Ormseth M, Major AS, Stafford JM, Linton MF, Fazio S (2016) Arterioscler Thromb Vasc Biol 36(8): 1483-95
    › Primary publication · 27365402 (PubMed) · PMC5346022 (PubMed Central)
  10. Local effects of human PCSK9 on the atherosclerotic lesion. Giunzioni I, Tavori H, Covarrubias R, Major AS, Ding L, Zhang Y, DeVay RM, Hong L, Fan D, Predazzi IM, Rashid S, Linton MF, Fazio S (2016) J Pathol 238(1): 52-62
    › Primary publication · 26333678 (PubMed) · PMC5346023 (PubMed Central)